These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27540530)

  • 1. Thymoquinone Could Increase The Efficacy of Tamoxifen Induced Apoptosis in Human Breast Cancer Cells: An In Vitro Study.
    Ganji-Harsini S; Khazaei M; Rashidi Z; Ghanbari A
    Cell J; 2016; 18(2):245-54. PubMed ID: 27540530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Doses of Thymoquinone and Ferulic Acid in Combination Effectively Inhibit Proliferation of Cultured MDA-MB 231 Breast Adenocarcinoma Cells.
    Al-Mutairi A; Rahman A; Rao MS
    Nutr Cancer; 2021; 73(2):282-289. PubMed ID: 32223348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymoquinone anticancer activity is enhanced when combined with royal jelly in human breast cancer.
    Moubarak MM; Chanouha N; Abou Ibrahim N; Khalife H; Gali-Muhtasib H
    World J Clin Oncol; 2021 May; 12(5):342-354. PubMed ID: 34131566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent Reactive Oxygen Species Generation and Aneuploidy Induction Contribute to Thymoquinone Anticancer Activity.
    Al-Hayali M; Garces A; Stocks M; Collins H; Bradshaw TD
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective role of thymoquinone against liver damage induced by tamoxifen in female rats.
    Suddek GM
    Can J Physiol Pharmacol; 2014 Aug; 92(8):640-4. PubMed ID: 24941454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The synergistic inhibitory effect of 5-aza-2-deoxycytidine and Tamoxifen on estrogen receptor alpha negative breast cancer cell lines in vitro].
    Tang B; Peng ZH; Jiang J
    Zhonghua Wai Ke Za Zhi; 2005 Dec; 43(23):1545-9. PubMed ID: 16412295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
    Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
    Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymoquinone Augments Cyclophosphamide-Mediated Inhibition of Cell Proliferation in Breast Cancer Cells.
    Khan A; Aldebasi YH; Alsuhaibani SA; Khan MA
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1153-1160. PubMed ID: 31030489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NADPH quinone oxidoreductase 1 mediates breast cancer cell resistance to thymoquinone-induced apoptosis.
    Sutton KM; Doucette CD; Hoskin DW
    Biochem Biophys Res Commun; 2012 Sep; 426(3):421-6. PubMed ID: 22960073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymoquinone synergizes gemcitabine anti-breast cancer activity via modulating its apoptotic and autophagic activities.
    Bashmail HA; Alamoudi AA; Noorwali A; Hegazy GA; AJabnoor G; Choudhry H; Al-Abd AM
    Sci Rep; 2018 Aug; 8(1):11674. PubMed ID: 30076320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regressions of Breast Carcinoma Syngraft Following Treatment with Piperine in Combination with Thymoquinone.
    Talib WH
    Sci Pharm; 2017 Jul; 85(3):. PubMed ID: 28671634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Thymoquinone on P53 Gene Expression and Consequence Apoptosis in Breast Cancer Cell Line.
    Dastjerdi MN; Mehdiabady EM; Iranpour FG; Bahramian H
    Int J Prev Med; 2016; 7():66. PubMed ID: 27141285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells.
    Kallio A; Zheng A; Dahllund J; Heiskanen KM; Härkönen P
    Apoptosis; 2005 Dec; 10(6):1395-410. PubMed ID: 16215679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymoquinone-loaded nanostructured lipid carrier exhibited cytotoxicity towards breast cancer cell lines (MDA-MB-231 and MCF-7) and cervical cancer cell lines (HeLa and SiHa).
    Ng WK; Saiful Yazan L; Yap LH; Wan Nor Hafiza WA; How CW; Abdullah R
    Biomed Res Int; 2015; 2015():263131. PubMed ID: 25632388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational and in vitro analyses on synergistic effects of paclitaxel and thymoquinone in suppressing invasive breast cancer cells.
    Khazaei MR; Bozorgi M; Khazaei M; Moradi A; Bozorgi A
    Mol Biol Rep; 2024 Mar; 51(1):388. PubMed ID: 38446390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo.
    Attoub S; Sperandio O; Raza H; Arafat K; Al-Salam S; Al Sultan MA; Al Safi M; Takahashi T; Adem A
    Fundam Clin Pharmacol; 2013 Oct; 27(5):557-69. PubMed ID: 22788741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
    Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
    Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of doxorubicin and retinoids on proliferation, necrosis and apoptosis in MCF-7 breast cancer cells.
    Czeczuga-Semeniuk E; Wołczyński S; Dabrowska M; Dziecioł J; Anchim T
    Folia Histochem Cytobiol; 2004; 42(4):221-7. PubMed ID: 15704648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-encapsulation of thymoquinone with docetaxel enhances the encapsulation efficiency into PEGylated liposomes and the chemosensitivity of MCF7 breast cancer cells to docetaxel.
    Odeh F; Naffa R; Azzam H; Mahmoud IS; Alshaer W; Al Bawab A; Ismail S
    Heliyon; 2019 Nov; 5(11):e02919. PubMed ID: 31844767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination Therapy of TRAIL and Thymoquinone Induce Breast Cancer Cell Cytotoxicity-Mediated Apoptosis and Cell Cycle Arrest.
    Abdel Salam NM; Abd-Rabou AA; Sharada HM; El Samea GGA; Abdalla MS
    Asian Pac J Cancer Prev; 2021 May; 22(5):1513-1521. PubMed ID: 34048180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.